Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Childhood Liposarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04996004
What this trial is testing

Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Pfizer 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686367
What this trial is testing

Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers

Who this might be right for
Metastatic Myxoid LiposarcomaMetastatic Synovial SarcomaUnresectable Myxoid Liposarcoma+1 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Early research (Phase 1)Active Not RecruitingNCT04377932
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Who this might be right for
Liver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more
Baylor College of Medicine 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694871
What this trial is testing

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Who this might be right for
Advanced Dedifferentiated LiposarcomaLocally Advanced Dedifferentiated LiposarcomaMetastatic Dedifferentiated Liposarcoma+3 more
Alliance for Clinical Trials in Oncology 77
Testing effectiveness (Phase 2)UnknownNCT02106312
What this trial is testing

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas

Who this might be right for
Myxoid Liposarcoma of Soft Tissue
The Netherlands Cancer Institute 80
Not applicableStudy completedNCT01841047
What this trial is testing

Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma

Who this might be right for
Liposarcoma
Institut Bergonié 48
Early research (Phase 1)Study completedNCT04242238
What this trial is testing

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Who this might be right for
SarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT02992743
What this trial is testing

Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma

Who this might be right for
Neoplasms
GlaxoSmithKline 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571
What this trial is testing

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more
National Cancer Institute LAO 66
Large-scale testing (Phase 3)UnknownNCT00334854
What this trial is testing

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
European Paediatric Soft Tissue Sarcoma Study Group 250
Testing effectiveness (Phase 2)Ended earlyNCT05116683
What this trial is testing

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Who this might be right for
LeiomyosarcomaLiposarcoma
Benjamin Izar 4
Testing effectiveness (Phase 2)Study completedNCT00356031
What this trial is testing

Bevacizumab and Radiation Therapy for Sarcomas

Who this might be right for
Soft Tissue SarcomaFibrous HistiocytomaLiposarcoma+3 more
Massachusetts General Hospital 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07823491
What this trial is testing

Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall

Who this might be right for
Resectable LiposarcomaResectable Soft Tissue SarcomaResectable Undifferentiated Pleomorphic Sarcoma
Ohio State University Comprehensive Cancer Center 228
Early research (Phase 1)Study completedNCT01426633
What this trial is testing

Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas

Who this might be right for
LeiomyosarcomaLiposarcoma
Heidelberg University 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04557449
What this trial is testing

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Who this might be right for
LiposarcomaProstate CancerBreast Neoplasms+1 more
Pfizer 362
Large-scale testing (Phase 3)Study completedNCT06058793
What this trial is testing

Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma

Who this might be right for
Liposarcoma, Dedifferentiated
Boehringer Ingelheim 138
Testing effectiveness (Phase 2)Study completedNCT00659360
What this trial is testing

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult FibrosarcomaAdult LeiomyosarcomaAdult Liposarcoma+12 more
National Cancer Institute (NCI) 17
Early research (Phase 1)Looking for participantsNCT05711615
What this trial is testing

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Who this might be right for
Metastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic Myxofibrosarcoma+9 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Next Page